Título não disponível

Por Andrea Aiello, Daniela Ritrovato, Claudia Pitotti
Publicado em 2018-10-01

Budget impact model of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease in Italy based on the FLAME study

Por Andrea Aiello, Daniela Ritrovato, Claudia Pitotti
Publicado em 2018-10-01

Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy

Por Nicola Ferrante, Daniela Ritrovato, Rossella Bitonti, Gianluca Furneri
Publicado em 2022-04-01

Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy.

Por Paolo Angelo Cortesi, Ippazio Cosimo Antonazzo, Claudio Gasperini, Mihaela Nica, Daniela Ritrovato, Lorenzo Giovanni Mantovani
Publicado em 2022-01-01